then you dont understand IVX - they have similiar space in terms of cancer treatment however they targeting ovarian so if they get deal BOOM also !!- they already have licenced cancer treatment technology so i reckon a partner is close too
INVION SECURES RESEARCH ALLIANCE WITH HUDSON INSTITUTE OF MEDICAL RESEARCH ― Hudson Institute is a leading Australian biomedical research institute recognised internationally for delivering better health through research into cancer and inflammation
― The alliance is aimed at advancing Invion’s licenced cancer treatment technology,
PhotosoftTM
― Hudson Institute will provide research and clinical expertise on a series of projects in collaboration with Invion
― Projects will target a range of common and difficult to treat cancers, starting with ovarian cancer ― Invion’s development costs are financed by a non-dilutive funding agreement with The Cho Group
- Forums
- ASX - By Stock
- IMU
- IMU Chart
IMU
imugene limited
Add to My Watchlist
0.00%
!
13.5¢
IMU Chart, page-55
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
- they already have licenced cancer treatment technology so i reckon a partner is close too 